Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XTLB Xtl生物制药

未开盘 04-25 16:00:00 EDT

2.40

-0.16

-6.25%

盘后2.40

+0.000.00%

18:29 EDT

最高2.49	最低2.35	成交量6,182
今开2.41	昨收2.56	日振幅5.47%
总市值1,308万	流通市值991.82万	总股本544.91万
成交额1.47万	换手率0.15%	流通股本413.26万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"Xtl生物制药","latestPrice":2.4,"timestamp":1714075200000,"preClose":2.56,"halted":0,"volume":6182,"hourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.4,"latestTime":"18:29 EDT","volume":20,"amount":46.905,"timestamp":1714084156500},"delay":0,"floatShares":4132579,"shares":5449061,"eps":-0.4121,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.16,"latestTime":"04-25 16:00:00 EDT","open":2.41,"high":2.49,"low":2.35,"amount":14735.8473218,"amplitude":0.054688,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.4121,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714118400000},"adr":0,"adjPreClose":2.56,"adrRate":100,"preHourTrading":{"tag":"盘前","latestPrice":2.46,"preClose":2.56,"latestTime":"08:43 EDT","volume":3,"amount":7.4200002000000005,"timestamp":1714048987258},"postHourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.4,"latestTime":"18:29 EDT","volume":20,"amount":46.905,"timestamp":1714084156500},"volumeRatio":0.312788},"requestUrl":"/m/hq/s/XTLB?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2430866032","title":"Xtl生物制药盘中异动 股价大跌7.42%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430866032","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430866032?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:37","pubTimestamp":1714052222,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时37分，Xtl生物制药股票出现波动，股价快速下跌7.42%。截至发稿，该股报2.37美元/股，成交量508股，换手率0.01%，振幅1.56%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.02%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521370287af6bf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521370287af6bf2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429798289","title":"Xtl生物制药盘中异动 股价大涨6.56%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429798289","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429798289?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:18","pubTimestamp":1713802700,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日00时18分，Xtl生物制药股票出现异动，股价大幅拉升6.56%。截至发稿，该股报2.60美元/股，成交量1.2453万股，换手率0.23%，振幅10.25%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为1.37%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。hCDR1 是一种合成肽，包含大约 20 个氨基酸残基。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423001821861e7e23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423001821861e7e23&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428751346","title":"Xtl生物制药盘中异动 大幅下挫6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428751346","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428751346?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:38","pubTimestamp":1713361082,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时38分，Xtl生物制药股票出现异动，股价急速下跌6.36%。截至发稿，该股报2.43美元/股，成交量7046股，换手率0.13%，振幅6.36%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.65%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213802878a20f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213802878a20f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426731946","title":"Xtl生物制药盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426731946","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426731946?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:08","pubTimestamp":1712934512,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日23时08分，Xtl生物制药股票出现异动，股价快速下挫5.07%。截至发稿，该股报2.62美元/股，成交量8304股，换手率0.15%，振幅4.35%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.06%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122308337a52790b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122308337a52790b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426497307","title":"Xtl生物制药盘中异动 快速下挫7.55%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426497307","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426497307?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:33","pubTimestamp":1712755983,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时33分，Xtl生物制药股票出现异动，股价急速跳水7.55%。截至发稿，该股报2.94美元/股，成交量2506股，换手率0.05%，振幅0.06%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.13%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021330387616855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021330387616855&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425277595","title":"Xtl生物制药盘中异动 股价大涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425277595","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425277595?lang=zh_cn&edition=full","pubTime":"2024-04-06 00:33","pubTimestamp":1712334832,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日00时33分，Xtl生物制药股票出现异动，股价快速上涨6.54%。截至发稿，该股报3.31美元/股，成交量3.6539万股，换手率0.67%，振幅6.43%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为1.05%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406003352791edbe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406003352791edbe0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424392966","title":"Xtl生物制药盘中异动 早盘急速跳水5.71%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424392966","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424392966?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:32","pubTimestamp":1712237555,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时32分，Xtl生物制药股票出现波动，股价快速下挫5.71%。截至发稿，该股报3.14美元/股，成交量1.931万股，换手率0.35%，振幅1.50%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.45%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040421323587de77c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040421323587de77c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424849209","title":"Xtl生物制药盘中异动 股价大涨5.67%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424849209","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424849209?lang=zh_cn&edition=full","pubTime":"2024-04-03 22:00","pubTimestamp":1712152812,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日22时00分，Xtl生物制药股票出现波动，股价大幅上涨5.67%。截至发稿，该股报2.98美元/股，成交量5.4316万股，换手率1.00%，振幅6.38%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.09%。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403220012861e3530&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403220012861e3530&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422188229","title":"Xtl生物制药盘中异动 早盘急速下跌7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422188229","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422188229?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:45","pubTimestamp":1711547148,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时45分，Xtl生物制药股票出现异动，股价快速下跌7.17%。截至发稿，该股报2.85美元/股，成交量6.1576万股，换手率1.13%，振幅7.17%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.10%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272145487a4f8802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272145487a4f8802&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422134786","title":"Xtl生物制药股价上涨13.17% 市值涨228.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422134786","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422134786?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:31","pubTimestamp":1711459909,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时31分，Xtl生物制药股票出现波动，股价急速拉升13.17%。截至发稿，该股报3.18美元/股，成交量58.8202万股，换手率10.79%，振幅2.85%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.41%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032621315087b7c88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032621315087b7c88c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422051083","title":"Xtl生物制药盘中异动 早盘急速上涨12.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422051083","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422051083?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373465,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Xtl生物制药股票出现异动，股价急速上涨12.21%。截至发稿，该股报2.94美元/股，成交量10.0401万股，换手率1.84%，振幅7.25%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.52%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252131058b613915&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252131058b613915&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421785819","title":"Xtl生物制药盘中异动 快速上涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421785819","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421785819?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:31","pubTimestamp":1711114267,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时31分，Xtl生物制药股票出现异动，股价急速上涨10.26%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.20%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222131088b5654fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222131088b5654fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421504198","title":"Xtl生物制药盘中异动涨6.41% 换手率达9.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421504198","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421504198?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:37","pubTimestamp":1711028259,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时37分，Xtl生物制药股票出现波动，股价急速拉升6.41%。截至发稿，该股报2.53美元/股，成交量51.088万股，换手率9.38%，振幅9.01%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.58%。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213739861e0184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213739861e0184&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":-0.2182},{"period":"3month","weight":1.7248},{"period":"6month","weight":1.9265},{"period":"1year","weight":1},{"period":"ytd","weight":1.376}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发，为了满足未得到满足的医疗需求。最近在致力于MM的治疗，精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.120788},{"month":2,"riseRate":0.4,"avgChangeRate":-0.024778},{"month":3,"riseRate":0.4,"avgChangeRate":0.168776},{"month":4,"riseRate":0.4,"avgChangeRate":-0.037067},{"month":5,"riseRate":0.230769,"avgChangeRate":-0.058161},{"month":6,"riseRate":0.538462,"avgChangeRate":0.010236},{"month":7,"riseRate":0.357143,"avgChangeRate":0.506157},{"month":8,"riseRate":0.357143,"avgChangeRate":-0.031253},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.074183},{"month":10,"riseRate":0.4,"avgChangeRate":-0.018436},{"month":11,"riseRate":0.4,"avgChangeRate":-0.045684},{"month":12,"riseRate":0.2,"avgChangeRate":-0.058576}],"exchange":"NASDAQ","name":"Xtl生物制药","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtl生物制药,XTLB,Xtl生物制药股票,Xtl生物制药股票老虎,Xtl生物制药股票老虎国际,Xtl生物制药行情,Xtl生物制药股票行情,Xtl生物制药股价,Xtl生物制药股市,Xtl生物制药股票价格,Xtl生物制药股票交易,Xtl生物制药股票购买,Xtl生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}